The Company's R&D strengths are in developing intellectual property in the area of non-infringing processes and resolving complex chemistry challenges. Furthermore we are developing new drug delivery systems, new dosage formulations, applying new technology for better processes. Development of analytical methods and specifications from raw materials, to non-compendia finished products is done.

Specialized Ophthalmology and ENT

We are focused on corneal disorders that lack effective treatment options and on retinal disorders that are increasing due to the aging of society. We manufacture nearly 30 Ophthalmic Products (Eye drops, eye ointments, diagnostic strips & tablets) & 10 ENT Products (Ear drops, nasal drops and tablets required by ENT specialists).

We are also expanding our ophthalmic related drug discovery, a field at the forefront of modern science. We are committed to discovering new breakthroughs in the treatment of eye disorders.

Analytical Development

We provide broad analytical support for drug discovery, pharmaceutical development and manufacturing. With years of industry experience, our analytical scientists understand pharmaceutical chemistry.

The technologies and instrumentation along with close collaboration with synthetic organic chemists ensures that the right questions are asked and the right tools are used to solve even the most challenging problems.

Formulation Development

Bell Pharma provides an integrated and customizable range of finished drug product services, including formulation development, clinical and commercial-scale manufacturing, packaging management. We offer services that combines scientific and regulatory expertise and specialized capabilities.